To expand the understanding of clinical characteristics among patients with suspected, probable or confirmed emerging infectious diseases, the World Health Organization (WHO) has established the Global Clinical Platform, which is a secure web-based database including individual-level, anonymized clinical data of patients from health facilities across the globe.

The WHO Global Clinical Platform is intended to provide Member States and health facilities with a standardized clinical data collection system to characterize the natural history of disease; identify risk factors for severe disease and poor outcomes; and describe disease evolution, treatment interventions and outcomes among adults, children and subpopulations, such as pregnant women, children and people living with HIV.

The Global Clinical Platform is currently receiving anonimized clinical data for patients with COVID-19, mpox and severe acute hepatitis of unknown aetiology in children. It will soon be updated to receive data on Ebola Virus disease.

For any additional questions, please contact: [email protected]

Global clinical platform terms of use.